We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $2 · 1 analysts
Stored first · Google News · Yahoo Finance (English)
Cresco Labs to report Q2FY26 results on August 6, 2026 - scanx.trade
Cresco Labs to report Q2FY26 results on August 6, 2026 scanx.trade
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026 Business Wire
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026
Cresco Labs holds the spotlight on cannabis strategy - Ad-hoc-news.de
Cresco Labs holds the spotlight on cannabis strategy Ad-hoc-news.de
Cresco Labs Stock - Long-term strategy in a shifting US cannabis market - Ad-hoc-news.de
Cresco Labs Stock - Long-term strategy in a shifting US cannabis market Ad-hoc-news.de
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $-0.04 | — | — | $165.88M | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2024. 08. 12. | Needham | — | Maintain | — → Hold | — | Needham: Hold |
| 2024. 06. 12. | Zuanic & Associates | — | Initiate coverage | — → Overweight | — | Zuanic & Associates: Overweight |
| 2024. 05. 16. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
| 2024. 05. 16. | Needham | — | Maintain | Hold → Hold | — | Needham: Hold |
| 2024. 03. 15. | Roth MKM | — | Maintain | Neutral → Neutral | — | Roth MKM: Neutral |
| 2023. 03. 20. | Wedbush | — | Maintain | — → Outperform | — | Wedbush: Outperform |
As of FY2025 · Source: SEC/DART + price data
No holdings data to show.